Star Combo Pharma Limited
Star Combo Pharma Limited
Your view on S66.AX
Overview
What the company does, where it operates, and who runs it.
About Star Combo Pharma Limited
- Industry
- Household & Personal Products
- Sector
- Consumer Defensive
- CEO
- Su Zhang
- Headquarters
- 171-177 Woodpark Road, Smithfield, NSW, AU
- Industry
- Household & Personal Products
- Sector
- Consumer Defensive
- CEO
- Su Zhang
- Headquarters
- 171-177 Woodpark Road, Smithfield, NSW, AU
Star Combo Pharma Limited is involved in the production and supply of health foods and dietary supplements across Australia and China. The company's activities are organized into two primary divisions: Star Combo and Austoyou Retail. It manages the full spectrum of natural health supplements and skincare products, encompassing their development, manufacturing, promotion, and sale. Distribution channels include a dedicated e-commerce platform for health-conscious consumers in China, alongside two brick-and-mortar retail stores situated in Sydney. Founded in 2004, Star Combo Pharma Limited's main office is located in Smithfield, Australia.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks the stock is worth vs. the current price.
FRC's fair value estimate for Star Combo Pharma Limited, and the rating behind it. S66.AX last traded at AUD 0.13, 3.2× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Star Combo Pharma Limited. Starting points for Star Combo Pharma Limited: P/E 3.2, EPS AUD 0.04, beta 0.34 — an Household & Personal Products name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Star Combo Pharma Limited. Star Combo Pharma Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Star Combo Pharma Limited. Trailing twelve-month EPS for Star Combo Pharma Limited stands at AUD 0.04. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Star Combo Pharma Limited. Star Combo Pharma Limited has reported as a listed company since 2018. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Star Combo Pharma Limited valued side by side against its closest peers. Star Combo Pharma Limited is measured against Household & Personal Products peers within the Consumer Defensive sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
Which funds and firms own the stock.
Which institutions hold Star Combo Pharma Limited, and how their positions are changing. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
Buying and selling by Star Combo Pharma Limited executives and directors. Shares of Star Combo Pharma Limited have traded between AUD 0.11 and AUD 0.28 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Star Combo Pharma Limited. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Star Combo Pharma Limited. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Star Combo Pharma Limited. Coverage tracks Star Combo Pharma Limited within Household & Personal Products (Consumer Defensive). Press releases and market coverage, newest first.